Matthew R Cooperberg

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort
    Matthew R Cooperberg
    University of California, San Francisco, Box 1695, 1600 Divisadero St, A 624, San Francisco, CA 94143 1695, USA
    J Clin Oncol 31:1428-34. 2013
  2. pmc Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis
    Matthew R Cooperberg
    Departments of Urology and Epidemiology and Biostatistics, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    BJU Int 111:437-50. 2013
  3. pmc Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis
    Matthew R Cooperberg
    Department of Urology, University of California San Francisco, 1600 Divisadero Street A 607, San Francisco, CA 94143 1695, USA
    J Natl Cancer Inst 101:878-87. 2009
  4. ncbi request reprint Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
    Cancer 107:2384-91. 2006
  5. doi request reprint Active surveillance for prostate cancer: progress and promise
    Matthew R Cooperberg
    Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
    J Clin Oncol 29:3669-76. 2011
  6. doi request reprint Treatment trends for stage I renal cell carcinoma
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 186:394-9. 2011
  7. pmc Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, CA, USA
    Cancer 116:5226-34. 2010
  8. pmc High-risk prostate cancer in the United States, 1990-2007
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115 1711, USA
    World J Urol 26:211-8. 2008
  9. pmc Time trends and local variation in primary treatment of localized prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Box 1695, 1600 Divisadero St, A 607, San Francisco, CA 94143 1695, USA
    J Clin Oncol 28:1117-23. 2010
  10. pmc Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, 1600 Divisadero St, A 607, San Francisco, CA 94143 1695, USA
    J Clin Oncol 27:4306-13. 2009

Detail Information

Publications79

  1. doi request reprint Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort
    Matthew R Cooperberg
    University of California, San Francisco, Box 1695, 1600 Divisadero St, A 624, San Francisco, CA 94143 1695, USA
    J Clin Oncol 31:1428-34. 2013
    ..We aimed to validate a previously described genetic risk score, denoted the cell-cycle progression (CCP) score, in predicting contemporary radical prostatectomy (RP) outcomes...
  2. pmc Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis
    Matthew R Cooperberg
    Departments of Urology and Epidemiology and Biostatistics, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    BJU Int 111:437-50. 2013
    ..g. intensity-modulated RT for low-risk disease, were dominated - that is, both more expensive and less effective than competing alternatives...
  3. pmc Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis
    Matthew R Cooperberg
    Department of Urology, University of California San Francisco, 1600 Divisadero Street A 607, San Francisco, CA 94143 1695, USA
    J Natl Cancer Inst 101:878-87. 2009
    ....
  4. ncbi request reprint Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
    Cancer 107:2384-91. 2006
    ..This study used a large external dataset to validate CAPRA...
  5. doi request reprint Active surveillance for prostate cancer: progress and promise
    Matthew R Cooperberg
    Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
    J Clin Oncol 29:3669-76. 2011
    ..Ultimately, by minimizing the harms of overtreating low-risk prostate cancer, active surveillance may help settle the controversy surrounding prostate cancer screening and management...
  6. doi request reprint Treatment trends for stage I renal cell carcinoma
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 186:394-9. 2011
    ..Previous reports suggest that nephron sparing surgery is underused for small renal cell carcinomas. We determined updated, population based treatment trends for stage I renal cell carcinoma...
  7. pmc Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, CA, USA
    Cancer 116:5226-34. 2010
    ....
  8. pmc High-risk prostate cancer in the United States, 1990-2007
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115 1711, USA
    World J Urol 26:211-8. 2008
    ..This study aimed to describe national trends in presentation, management, and outcomes for men with high risk prostate cancer...
  9. pmc Time trends and local variation in primary treatment of localized prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Box 1695, 1600 Divisadero St, A 607, San Francisco, CA 94143 1695, USA
    J Clin Oncol 28:1117-23. 2010
    ..A critical need exists for high-quality comparative effectiveness research in localized prostate cancer to help guide treatment decision making...
  10. pmc Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, 1600 Divisadero St, A 607, San Francisco, CA 94143 1695, USA
    J Clin Oncol 27:4306-13. 2009
    ..We compared risk features between large disease registries from the United States and Japan, and aimed to build and validate a risk prediction model applicable to PADT patients...
  11. doi request reprint Defining high quality health care
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA
    Urol Oncol 27:411-6. 2009
    ..It is crucial, therefore, that physicians assume increasing leadership roles in efforts to define, measure, report, and improve quality of care...
  12. pmc The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, California, USA
    Cancer 117:5039-46. 2011
    ..They aimed to develop a similar postsurgical score with improved accuracy via incorporation of pathologic data...
  13. pmc The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
    Matthew R Cooperberg
    University of California, San Francisco, San Francisco, USA
    J Urol 173:1938-42. 2005
    ..We devised a novel risk assessment tool which would be a strong predictor of outcome across various levels of risk, and which could be easily applied and intuitively understood...
  14. ncbi request reprint Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE
    Joseph A Mitchell
    Department of Urology, Urology Outcomes Research Group, University of California, San Francisco, USA
    J Urol 173:1126-31. 2005
    ..We tested the 2 instruments in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) database, a national registry of patients with prostate cancer, to assess their accuracy in a community based cohort...
  15. doi request reprint Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry
    Natalia Sadetsky
    Department of Urology, University of California, San Francisco, San Francisco, California, USA
    Cancer 117:4406-13. 2011
    ..In this study, the authors evaluated the effect of ADT administered as monotherapy and in combination with local treatment on physical well-being in a longitudinal sample of men with prostate cancer...
  16. doi request reprint Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance
    Sima P Porten
    Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1600 Divisadero St, Box 1695, San Francisco, CA 94143 1695, USA
    J Clin Oncol 29:2795-800. 2011
    ..Active surveillance is now considered a viable treatment option for men with low-risk prostate cancer. However, little is known regarding changes in Gleason grade on serial biopsies over an extended period of time...
  17. doi request reprint The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California 94143, USA
    J Urol 185:1656-60. 2011
    ..We assessed whether an association exists between a change in prostate specific antigen and biopsy progression in men on active surveillance...
  18. ncbi request reprint The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE)
    Jason W Anast
    Department of Urology and UCSF Mt Zion Comprehensive Cancer Center, University of California, San Francisco, USA
    J Urol 173:1132-8. 2005
    ..We determined if there are differences in the HRQOL of obese men at diagnosis and after radical prostatectomy compared to the HRQOL of men with normal body mass index (BMI)...
  19. ncbi request reprint Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE
    William W Bassett
    Department of Urology, Urologic Outcomes Research Group, University of California, School of Medicine, Comprehensive Cancer Center, San Francisco, California, USA
    Urology 66:1060-5. 2005
    ..To determine the association between obesity and prostate cancer recurrence after primary treatment with radical prostatectomy...
  20. doi request reprint Changes in specific domains of sexual function and sexual bother after radical prostatectomy
    Jesse D Le
    University of California San Francisco, San Francisco, CA, USA
    BJU Int 106:1022-9. 2010
    ....
  21. ncbi request reprint Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE
    David M Latini
    Department of Urology, Program in Urologic Oncology, Urology Outcomes Research Group and UCSF Comprehensive Cancer Center, University of California, San Francisco, 94143, USA
    Cancer 106:789-95. 2006
    ..The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional database of men with prostate cancer...
  22. ncbi request reprint Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE
    Susan R Harlan
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Mt Zion Comprehensive Cancer Center, University of California San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA
    J Urol 170:1804-7. 2003
    ..Watchful waiting (WW) is one option for men with clinically localized prostate cancer. We examined temporal trends in the use of WW, as well as sociodemographic and clinical profiles of men who choose this form of management...
  23. pmc Outcomes of active surveillance for men with intermediate-risk prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    J Clin Oncol 29:228-34. 2011
    ..Current risk stratification schema identify patients with low-risk disease who are presumed to be most suitable for AS. However, some men with higher risk disease also elect AS; outcomes for such men have not been widely reported...
  24. doi request reprint Active surveillance for the management of prostate cancer in a contemporary cohort
    Marc A Dall'Era
    Department of Urology and the Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:2664-70. 2008
    ..In this article, the authors report their experience in a contemporary cohort of men with prostate cancer who were managed with active surveillance...
  25. doi request reprint Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 184:114-9. 2010
    ..We hypothesize that in the context of data available from a contemporary biopsy, clinical stage no longer offers meaningful independent prognostic information for clinically localized prostate cancer...
  26. pmc The changing face of low-risk prostate cancer: trends in clinical presentation and primary management
    Matthew R Cooperberg
    University of California San Francisco Mt Zion Cancer Center, 1600 Divisadero St, 3rd Floor, San Francisco, CA 94115 1711, USA
    J Clin Oncol 22:2141-9. 2004
    ..We sought to characterize temporal trends in clinical presentation and primary disease management among patients with low-risk prostate cancer...
  27. doi request reprint Factors associated with downgrading in patients with high grade prostate cancer
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA
    Urol Oncol 31:442-7. 2013
    ..To determine the factors associated with downgrading between biopsy and prostatectomy in the contemporary era using extended-template biopsy techniques...
  28. pmc Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy
    Michael L Eisenberg
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    Eur Urol 57:622-9. 2010
    ..The prognostic meaning of an undetectable ultrasensitive prostate-specific antigen (USPSA) level after prostatectomy remains unclear...
  29. pmc Urologist density and county-level urologic cancer mortality
    Anobel Y Odisho
    Department of Urology, University of California, San Francisco, San Francisco, CA 94143 1695, USA
    J Clin Oncol 28:2499-504. 2010
    ..The goal of this study was to determine the effect of increasing urologist density on local prostate, bladder, and kidney cancer mortality...
  30. doi request reprint The epidemiology of high-risk prostate cancer
    Sanoj Punnen
    Helen Diller Comprehensive Cancer Center, University of California, San Francisco, California, USA
    Curr Opin Urol 23:331-6. 2013
    ..The purpose of this review is to summarize the epidemiology, risk factors, and treatment trends of men with high-risk prostate cancer...
  31. doi request reprint How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
    Sanoj Punnen
    Department of Urology, University of California San Francisco UCSF Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1695, USA
    BJU Int 112:E314-20. 2013
    ..We found no difference in positive margin rates or likelihood of prostate cancer recurrence. This adds to the growing evidence that RARP is a safe option for men with high-risk disease...
  32. ncbi request reprint Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urology Outcomes Research Group, University of California San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA
    J Urol 170:905-8. 2003
    ..Veterans Affairs (VA) health care system investigators perform large clinical trials in prostate cancer treatment but potential differences between VA and other patient cohorts have not been explored systematically...
  33. ncbi request reprint Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure)
    Kirsten L Greene
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco 94115 1711, USA
    J Urol 171:2255-9. 2004
    ..We assessed the performance of the Kattan nomogram using the Cancer of the Prostate Strategic Urological Research Endeavor database, a national, largely community based observational disease registry...
  34. pmc Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology
    Anobel Y Odisho
    Department of Urology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    Eur Urol 63:936-40. 2013
    ....
  35. doi request reprint Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era
    Allison S Glass
    Department of Urology, University of California, San Francisco, CA, USA
    Urology 82:60-5. 2013
    ..To describe how demographic and diagnostic characteristics of men with prostate cancer in the United States have changed since 1999, using data from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry...
  36. ncbi request reprint Who is the average patient presenting with prostate cancer?
    Kirsten L Greene
    Department of Urology, UCSF Mt Zion Comprehensive Cancer Center, University of California San Francisco, California, USA
    Urology 66:76-82. 2005
    ..Patients report average or above-average pretreatment health-related QOL for all scales based on 2 validated instruments. In this cohort, more patients chose radical prostatectomy than any other form of treatment...
  37. ncbi request reprint Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)
    Matthew R Cooperberg
    Department of Urology, UCSF Mt Zion Comprehensive Cancer Center, University of California, San Francisco 94115 1711, USA
    J Urol 170:S21-5; discussion S26-7. 2003
    ..We designed a study to characterize time trends in these parameters and their impact on patient risk stratification...
  38. doi request reprint A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer
    Sanoj Punnen
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143 1695, USA
    BJU Int 112:E67-75. 2013
    ..To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up...
  39. doi request reprint The quantitative Gleason score improves prostate cancer risk assessment
    Adam C Reese
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 118:6046-54. 2012
    ..They hypothesize that the qGS can improve prostate cancer risk stratification and help prevent the overtreatment of patients with clinically indolent tumors...
  40. doi request reprint Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA
    BJU Int 105:88-92. 2010
    ..To compare rates of lymph node dissection (LND) and nodal yields between patients treated with open radical retropubic prostatectomy (ORRP) and robot-assisted RRP (RARP) in a contemporary single-institution series...
  41. pmc Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
    Sanoj Punnen
    Department of Urology, University of California, San Francisco, CA, USA
    BJU Int 109:1520-4. 2012
    ..This suggests that the current definition of potency, inclusive of medication use, is valid with respect to sexual bother...
  42. doi request reprint Inaccuracies in assignment of clinical stage for localized prostate cancer
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:283-9. 2011
    ..One explanation for this lack of predictive power may be the inaccurate application of staging criteria...
  43. pmc National practice patterns and time trends in androgen ablation for localized prostate cancer
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California, San Francisco UCSF Mt Zion Comprehensive Cancer Center, UCSF, San Francisco 941150 1711, USA
    J Natl Cancer Inst 95:981-9. 2003
    ..We describe national trends in the use of androgen deprivation therapy for localized disease...
  44. doi request reprint Risk-based prostate cancer screening: who and how?
    Allison S Glass
    Department of Urology, University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1695, San Francisco, CA 94143 1695, USA
    Curr Urol Rep 14:192-8. 2013
    ..Optimal use of existing and future tools will help alleviate the problems of overdiagnosis and overtreatment of low-risk prostate cancer without reversing the substantial mortality declines that have been achieved in the screening era...
  45. doi request reprint Active surveillance for prostate cancer: a systematic review of the literature
    Marc A Dall'Era
    Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Eur Urol 62:976-83. 2012
    ..Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions...
  46. doi request reprint Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians
    Gregory E Tasian
    Department of Urology, University of California, San Francisco, CA 94143, USA
    Urol Oncol 30:155-60. 2012
    ....
  47. pmc The example of CaPSURE: lessons learned from a national disease registry
    Sima P Porten
    Department of Urology, UCSF Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA
    World J Urol 29:265-71. 2011
    ....
  48. ncbi request reprint Prostate cancer 2004: insights from national disease registries
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, University of California San Francisco, California 94115 1711, USA
    Oncology (Williston Park) 18:1239-47; discussion 1248-50, 1256-8. 2004
    ..The availability of these large databases of patients will be a tremendous asset as prostate cancer management continues to evolve in the coming years...
  49. doi request reprint Active surveillance for early-stage prostate cancer: review of the current literature
    Marc A Dall'Era
    Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:1650-9. 2008
    ..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
  50. ncbi request reprint The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry
    Matthew R Cooperberg
    Department of Urology, University of California San Francisco Mt Zion Comprehensive Cancer Center, San Francisco, California 94115 1711, USA
    J Urol 171:1393-401. 2004
    ..The epidemiology and treatment of prostate cancer have changed dramatically in the prostate specific antigen era. A large disease registry facilitates the longitudinal observation of trends in disease presentation, management and outcomes...
  51. doi request reprint Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA
    J Urol 179:2131-5. 2008
    ..The proportion of renal cell carcinoma cases diagnosed at stage I is known to be increasing significantly. We characterized stage I tumors further in terms of tumor size at diagnosis using a large national cancer registry...
  52. pmc In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT
    Youngho Seo
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143 0946, USA
    J Nucl Med 51:31-6. 2010
    ..We have developed an in vivo method to quantify antibody uptake using (111)In-capromab pendetide SPECT combined with CT (SPECT/CT). Our goal was to evaluate this method for potential grading of prostate tumors...
  53. pmc The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease
    Sima P Porten
    Department of Urology, University of California, San Francisco, USA
    BJU Int 105:472-5. 2010
    ....
  54. doi request reprint Patients with primary hyperparathyroidism--why do some form stones?
    Aaron D Berger
    Department of Urology, University of California San Francisco, San Francisco, California, USA
    J Urol 181:2141-5. 2009
    ..We evaluated the metabolic stone profile in patients presenting for parathyroid surgery and determined whether there were differences between those with and without a history of urinary stones...
  55. pmc Androgen deprivation therapy and cardiovascular risk
    Sanoj Punnen
    University of California, San Francisco, Department of Urology, 1600 Divisadero St, Box 1695, San Francisco, CA 94143 1695, USA
    J Clin Oncol 29:3510-6. 2011
    ..This study assessed mortality outcomes in a large national registry to further elucidate the association between treatment selection and cause of mortality...
  56. ncbi request reprint How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California, San Francisco Mt Zion Comprehensive Cancer Center, San Francisco, California 94143, USA
    Urology 61:190-6. 2003
    ..The accurate assessment of sexual function is critical for the evaluation of outcomes after treatment of prostate cancer. The assessments of potency typically used in this context, however, may be oversimplified...
  57. ncbi request reprint Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE
    Christopher J Kane
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California, San Francisco Comprehensive Cancer Center, University of California, San Francisco, USA
    J Urol 173:732-6. 2005
    ..We investigated the association of obesity with prostate cancer case demographics and clinical disease features at presentation...
  58. pmc Role of active surveillance in the management of localized prostate cancer
    Allison S Glass
    Department of Urology, University of California San Francisco, CA 94143 1695, USA
    J Natl Cancer Inst Monogr 2012:202-6. 2012
    ..Incorporation of novel biomarkers as well as advanced imaging techniques may improve surveillance strategies by better defining eligibility as well as improving prompt detection of disease progression...
  59. ncbi request reprint Patterns of practice in the United States: insights from CaPSURE on prostate cancer management
    Matthew R Cooperberg
    University of California, San Francisco, Mount Zion Cancer Center, 1600 Divisadero Street, 6th Floor, San Francisco, CA 94115 1711, USA
    Curr Urol Rep 5:166-72. 2004
    ....
  60. pmc Contemporary trends in low risk prostate cancer: risk assessment and treatment
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94115, USA
    J Urol 178:S14-9. 2007
    ..We updated national risk trends in prostate cancer with a focus on low risk tumors, reexamined trends in primary treatment for low risk tumors and substratified patients at low risk based on pretreatment clinical data...
  61. doi request reprint Health related quality of life in patients treated with multimodal therapy for prostate cancer
    Alex K Wu
    Department of Urology, University of California, San Francisco, San Francisco, California 94143 1695, USA
    J Urol 180:2415-22; discussion 2422. 2008
    ..However, the effects of multimodal therapy on health related quality of life have not been comprehensively described. We further characterized health related quality of life in patients treated with multimodal therapy...
  62. doi request reprint Candidate quality of care indicators for localized bladder cancer
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA
    Urol Oncol 27:435-42. 2009
    ..The urologic oncology community should take a strong lead in achieving consensus regarding the definition, assessment, and reporting of quality of care data for bladder cancer...
  63. doi request reprint Geographic distribution of urologists throughout the United States using a county level approach
    Anobel Y Odisho
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 181:760-5; discussion 765-6. 2009
    ..We assessed the geographic distribution of urologists throughout the United States at the county level and determined the county characteristics associated with increased urologist density...
  64. pmc Impact of age at diagnosis on prostate cancer treatment and survival
    Seth K Bechis
    Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143 1695, USA
    J Clin Oncol 29:235-41. 2011
    ..As a result, age often plays a role in treatment choice. However, the relationships among age, disease risk, and prostate cancer-specific survival have not been well established...
  65. doi request reprint Disproportionate presentation of high risk prostate cancer in a safety net health system
    Sima P Porten
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center and San Francisco General Hospital, San Francisco, California 94143 1695, USA
    J Urol 184:1931-6. 2010
    ..We describe prostate cancer characteristics in men treated in a public health system and hypothesize a disproportionate burden of high risk disease in this population...
  66. doi request reprint Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis
    Scott M Castle
    Department of Urology, University of California San Francisco, San Francisco, California, USA
    J Urol 184:579-83. 2010
    ..We determined whether repeat 24-hour urine collection provides information similar to that of the initial 24-hour urine collection and whether repeat collection is necessary...
  67. doi request reprint High-risk nonmuscle invasive bladder cancer: definition and epidemiology
    Sima P Porten
    Department of Urology, UCSF Helen Diller Comprehensive Cancer Center, University of California, San Francisco, California, USA
    Curr Opin Urol 22:385-9. 2012
    ..Precise definition and risk stratification are paramount in this group as high-risk patients have higher rates of progression and mortality and may benefit from early identification and aggressive treatment...
  68. doi request reprint Gender differences in subcutaneous and perirenal fat distribution
    Brian H Eisner
    Department of Urology, GRB 1102, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Surg Radiol Anat 32:879-82. 2010
    ..Body mass index (BMI) has been shown to influence the outcome of various surgical procedures. The purpose of this study is to assess the relationship between BMI, gender, and the distribution of subcutaneous and perirenal fat...
  69. doi request reprint Management of localized prostate cancer in men over 65 years
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Curr Opin Urol 19:309-14. 2009
    ..However, the majority of tumors are still detected among men over 65-years-old. The appropriate management of localized disease among these older men is controversial...
  70. ncbi request reprint Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco Mt Zion Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA
    J Urol 168:491-5. 2002
    ..In this study imaging test utilization rates were analyzed in a contemporary group of patients, and clinical and demographic predictors of testing were identified...
  71. ncbi request reprint Health related quality of life significance of single pad urinary incontinence following radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco Mt Zion Comprehensive Cancer Center, 94115 1711, USA
    J Urol 170:512-5. 2003
    ..We postulated that under appreciated health related quality of life (HRQOL) differences may exist between patients requiring 1 pad daily and those who do not require pads...
  72. ncbi request reprint Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Mt Zion Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street 3rd Floor, San Francisco, CA 94115 1711, USA
    Surgery 135:452-3; discussion 454. 2004
  73. ncbi request reprint Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, San Francisco, California 94143, USA
    Int J Urol 14:1113-5. 2007
    ..027; women 7% vs 17%, P = 0.04). The mechanism for the apparent protective effect of OCS on rates of nephrolithiasis is unclear, and further research is required to elucidate the variable penetrance of nephrolithiasis among PHPT patients...
  74. ncbi request reprint Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature
    Affonso H L A Camargo
    Department of Urology, University of California, San Francisco, School of Medicine, San Francisco, California 94143 0738, USA
    Urology 65:882-7. 2005
    ..Minimally invasive methods for the treatment of peripelvic renal cysts, including laparoscopic decortication, have recently become more common...
  75. ncbi request reprint Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection
    Matthew R Cooperberg
    Department of Urology, University of California San Francisco, California, USA
    Fertil Steril 84:672-7. 2005
    ..To determine whether center to center discrepancies in the ability to locate sperm in infertile testes with abnormal histology stems in part from inconsistencies in pathologists' readings of testis biopsies...
  76. ncbi request reprint The changing face of prostate cancer
    Matthew R Cooperberg
    Department of Urology, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115 1711, USA
    J Clin Oncol 23:8146-51. 2005
    ....
  77. ncbi request reprint Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells
    Bin Liu
    Department of Anesthesia and Pharmaceutical Chemistry, University of California at San Francisco, San Francisco General Hospital, California, USA
    Cancer Res 64:704-10. 2004
    ..Targeting components of this epitope space may facilitate development of immunotherapeutic and small molecule-based strategies as well as the use of other therapeutic agents that rely upon delivery to the interior of the tumor cell...
  78. ncbi request reprint Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002
    Matthew R Cooperberg
    Urologic Outcomes Research Group, Program in Urologic Oncology, Department of Urology, University of California San Francisco Comprehensive Cancer Center, California 94115 1711, USA
    J Urol 178:2103-8; discussion 2108. 2007
    ..The net effect of these pressures may be the regionalization of care. We quantified trends in the regionalization of inpatient care for urological oncology in a national administrative database...
  79. doi request reprint Renal cell cancer stage migration: analysis of the National Cancer Data Base
    Christopher J Kane
    Division of Urology, Department of Surgery, University of California at San Diego Medical Center, San Diego, CA 92103 8897, USA
    Cancer 113:78-83. 2008
    ..The aim of the study was to analyze patterns of disease presentation and outcome of RCC by AJCC stage using data from the National Cancer Data Base (NCDB) over a 12-year period...